Enable timely isolation of infected patients in acute care settings4
Diagnosis in primary care is usually based on symptoms and local epidemiology3
RSV is under-diagnosed and under-reported in adults, in part because:
RNA detection by RT-PCR1,2
Antigen detection by ELISA or immunofluorescence1,2
Culture isolation1,2
Diagnosis of RSV in adults may help to:
Vaccines to help protect against RSV in the older adult and maternal populations, as well immunisations to help protect infants are licensed in the UK, but no National Immunisation Programme for RSV in the UK currently exists.6
Infection prevention and control measures to limit the spread of RSV such as those below can help reduce the risk of disease transmission.7
Supportive care is the basis of therapy for acute RSV infection in adults, and may include bronchodilators, supplemental oxygen, fluid replacement and antipyretics9
ELISA, enzyme-linked immunosorbent assay; LRTI, lower respiratory tract infection; PCR, Polymerase chain reaction; RT-PCR, reverse transcription PCR; RSV, respiratory syncytial virus
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
©2023 GSK group of companies. All rights reserved.
June 2024 | NX-GB-AVU-WCNT-230001 (V2.0)